Literature DB >> 7678111

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.

P Tan1, C Anasetti, J A Hansen, J Melrose, M Brunvand, J Bradshaw, J A Ledbetter, P S Linsley.   

Abstract

The specificity of T lymphocyte activation is determined by engagement of the T cell receptor (TCR) by peptide/major histocompatibility complexes expressed on the antigen-presenting cell (APC). Lacking costimulation by accessory molecules on the APC, T cell proliferation does not occur and unresponsiveness to subsequent antigenic stimulus is induced. The B7/BB1 receptor on APCs binds CD28 and CTLA-4 on T cells, and provides a costimulus for T cell proliferation. Here, we show that prolonged, specific T cell hyporesponsiveness to antigenic restimulation is achieved by blocking the interaction between CD28 and B7/BB1 in human mixed leukocyte culture (MLC). Secondary T cell proliferative responses to specific alloantigen were inhibited by addition to the primary culture of monovalent Fab fragments of anti-CD28 monoclonal antibody (mAb) 9.3, which block interaction of CD28 with B7/BB1 without activating T cells. Hypo-responsiveness was also induced in MLC by CTLA4Ig, a chimeric immunoglobulin fusion protein incorporating the extracellular domain of CTLA-4 with high binding avidity for B7/BB1. Cells previously primed could also be made hyporesponsive, if exposed to alloantigen in the presence of CTLA4Ig. Maximal hyporesponsiveness was achieved in MLC after 2 d of incubation with CTLA4Ig, and was maintained for at least 27 d after removal of CTLA4Ig. Accumulation of interleukin 2 (IL-2) and interferon gamma but not IL-4 mRNA was blocked by CTLA4Ig in T cells stimulated by alloantigen. Antigen-specific responses could be restored by addition of exogenous IL-2 at the time of the secondary stimulation. Addition to primary cultures of the intact bivalent anti-CD28 mAb 9.3, or B7/BB1+ transfected CHO cells or exogenous IL-2, abrogated induction of hyporesponsiveness by CTLA4Ig. These data indicate that interaction of CD28 with B7/BB1 during TCR engagement with antigen is required to maintain T cell competence and that blocking such interaction can result in a state of T cell hyporesponsiveness.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678111      PMCID: PMC2190874          DOI: 10.1084/jem.177.1.165

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses.

Authors:  R C Nowinski; M E Lostrom; M R Tam; M R Stone; W N Burnette
Journal:  Virology       Date:  1979-02       Impact factor: 3.616

2.  Antigen-specific functions of a CD4+ subset of human T lymphocytes with granular morphology.

Authors:  Y Morishita; P J Martin; M A Bean; H Yamada; J A Hansen
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

3.  Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness.

Authors:  H Quill; R H Schwartz
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

4.  Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.

Authors:  T Yokota; T Otsuka; T Mosmann; J Banchereau; T DeFrance; D Blanchard; J E De Vries; F Lee; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen.

Authors:  Y Liu; B Jones; W Brady; C A Janeway; P S Linsley; P S Linley
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

6.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

Authors:  D J Lenschow; Y Zeng; J R Thistlethwaite; A Montag; W Brady; M G Gibson; P S Linsley; J A Bluestone
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

7.  Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones.

Authors:  M K Jenkins; D M Pardoll; J Mizuguchi; T M Chused; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.

Authors:  P S Linsley; P M Wallace; J Johnson; M G Gibson; J L Greene; J A Ledbetter; C Singh; M A Tepper
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

9.  Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation.

Authors:  D B Lewis; A Larsen; C B Wilson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

10.  Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo.

Authors:  M K Jenkins; R H Schwartz
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  96 in total

1.  Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.

Authors:  Sten-Erik Bergström; Mehmet Uzunel; Toomas Talme; Eva Bergdahl; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 2.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

3.  The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury.

Authors:  M Takada; A Chandraker; K C Nadeau; M H Sayegh; N L Tilney
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 4.  Current and future therapies for myasthenia gravis.

Authors:  Q Yi; A K Lefvert
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

5.  Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade.

Authors:  S Hanabuchi; T Ohashi; Y Koya; H Kato; F Takemura; K Hirokawa; T Yoshiki; H Yagita; K Okumura; M Kannagi
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 6.  Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.

Authors:  W C Gause; J F Urban; P Linsley; P Lu
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

7.  Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.

Authors:  Yongzhu Jin; Qingyin Zhang; Jie Hao; Xiang Gao; Yinglu Guo; Shusheng Xie
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells.

Authors:  R G Bryan; Y Li; J H Lai; M Van; N R Rice; R R Rich; T H Tan
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.

Authors:  C D Gimmi; G J Freeman; J G Gribben; G Gray; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

10.  Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

Authors:  R S McHugh; S N Ahmed; Y C Wang; K W Sell; P Selvaraj
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.